The Discounted Cash Flow (DCF) valuation of Adamis Pharmaceuticals Corp (ADMP) is (98.57) USD. With the latest stock price at 0.78 USD, the upside of Adamis Pharmaceuticals Corp based on DCF is -12817.2%.
Based on the latest price of 0.78 USD and our DCF valuation, Adamis Pharmaceuticals Corp (ADMP) is a sell. selling ADMP stocks now will result in a potential gain of 12817.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 7.3% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (216.07) - (65.78) | (98.57) |
| Upside | -27977.3% - -8586.8% | -12817.2% |